- AU$47.54m
- AU$53.24m
- AU$83.62m
- 55
- 66
- 30
- 51
Annual cashflow statement for SomnoMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.042 | 0.011 | 0.016 | 0.011 | 0.007 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.55 | 5.19 | 2.71 | 1.86 | -3.88 |
| Capital Expenditures | -1.66 | -2.19 | -4.13 | -8.79 | -6.41 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.028 | 0.357 | -0.236 | 0.317 | 0 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.63 | -1.83 | -4.37 | -8.47 | -6.41 |
| Financing Cash Flow Items | -0.073 | -0.617 | 0 | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.38 | 18.9 | -6.8 | 2.09 | 6.61 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.69 | 22.5 | -9.06 | -5.47 | -3.69 |